EANO 2026

September 24-27, 2026
Rome, Italy

21st Meeting of the European Association of Neuro-Oncology

Explore more Neuro-Oncology congress materials

Results(2)

Neuro-Oncology

Dordaviprone (ONC201) in a Pediatric Patient With Recurrent H3 K27M-Mutant Diffuse Glioma and Leptomeningeal Disease

Author(s): Gabriel Batistella, Felipe D’Almeida Costa, Tomás Freddi et al.

Response by RANO 2.0 Criteria in ONC201 (Dordaviprone)-Treated Patients With Recurrent H3 K27M-Mutant Diffuse Midline Glioma

Author(s): Timothy Cloughesy, MD, Joshua E. Allen, PhD, Isabel Arrillaga-Romany, MD, PhD et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.